March 7, 2016
Lilly and Novartis reveal separate studies on plaque psoriasis
Good news for patients with moderate-to-severe plaque psoriasis. In only two days two big pharmaceutical companies have issued press releases about…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
February 22, 2016
FDA Accepts Sanofi NDA for Combination of Insulin Glargine and Lixisenatide (diabetes)
The U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Sanofi’s investigational fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist lixisenatide for the treatment of adults with type 2 diabetes.
February 19, 2016
AstraZeneca’s Brilique OK for marketing in EU
The European Commission has granted to AstraZeneca marketing authorisation for Brilique (ticagrelor) at a new 60mg dose for the treatment of patients who have suffered a heart attack at least one year prior and are at high risk of developing a further atherothrombotic event.
February 17, 2016
Durvalumab granted BTD by FDA for cancer patients
AstraZeneca and MedImmune, its global biologics research and development arm, on Wednesday announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) for durvalumab (MEDI4736), an investigational human monoclonal antibody directed against programmed death ligand-1 (PD-L1), for the treatment of patients with PD-L1 positive inoperable or metastatic urothelial bladder cancer whose tumour has progressed during or after one standard platinum-based regimen.
February 2, 2016
GSK and J&J back $1billion biotech spin-off from Index Ventures
Index Ventures, an early investor in technology hits like Skype and Dropbox, is spinning off its biotech portfolio into a new $1 billion (695 million pounds) business, with backing from drug giants GlaxoSmithKline and Johnson & Johnson .
February 2, 2016
Premaitha partners with Leeds Teaching Hositals NHS Trust to provide NIPT screening service
Premaitha Health, the developer of IONA test, has partnered with Leeds Teaching Hospitals NHS Trust to provide a private NIPT…
January 29, 2016
Roche annual profit disappoints, outlook muted
Cancer drug maker Roche followed Swiss rival Novartis in disappointing shareholders with a muted forecast for the year, sending its shares lower on Thursday.
January 29, 2016
Charterhouse begins groundwork for $700 million-plus Doc Generici sale -sources
By Pamela Barbaglia LONDON (Reuters) – European buyout firm Charterhouse [CHCAP.UL] is preparing for the sale of its Italian generic…
January 23, 2016
Hikma’s buying of Roxane from Boehringer general meeting in February
Hikma Pharmaceuticals has prepared a combined Prospectus that contains the formal notice of meeting for the general meeting, to be…
January 21, 2016
Five charged in U.S. with stealing secrects from GlaxoSmithKline
Five charged in U.S. with stealing secrects from GlaxoSmithKline